Chiara F Magnani

7PUBLICATIONS
23CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Electrochemical energy storage and conversion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 11, 2026
A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells.

|Mar 30, 2026
Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia.

Mara Hofstetter, Laura Volta, Christian Koch

|Mar 17, 2026
A bispecific anti-fluorescein x anti-CD3 T-cell engager in combination with fluoresceinated adaptors enables lysis of AML cells.

Laura G Volta, Celeste Gobbi, Christian Koch

|Feb 11, 2026
Genetically engineered ErbB2 overexpression sensitizes organoid-derived tumors to checkpoint inhibition in a syngeneic model of gastric cancer.

Jiazhuo He, Lydia Kirsche, Zuzana Nascakova

|Oct 24, 2025
Acquisition of an immunosuppressive microenvironment after anti-CD19 CAR T-cell therapy is associated with T-cell dysfunction and resistance.

Marianna Ponzo, Lorenzo Drufuca, Chiara Buracchi

|Apr 03, 2025
Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation.

Federico Lussana, Chiara F Magnani, Stefania Galimberti

Pageof 2

Frequent Collaborators

5 joint publications

Christian Pellegrino

4 joint publications

Laura Volta

4 joint publications

Christian Koch

4 joint publications

Florin Schneiter